<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="20/02/2006" creator="Hitomi MASUDA" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1851861">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>1851861</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Transactivation of the <term sem="DNA_domain_or_region" id="T1" lex="human_immunodeficiency_virus_promoter"><term sem="Virus" id="T2" lex="human_immunodeficiency_virus">human immunodeficiency virus</term> promoter</term> by <cons sem="(AND Virus Virus)" id="T3" lex="(AND human_herpesvirus_6_(HHV-6)_strain_GS human_herpesvirus_6_(HHV-6)_strain_Z-29)"><frag id="F1"><term sem="Virus" id="T4" lex="human_herpesvirus_6">human herpesvirus 6</term> (<term sem="Virus" id="T5" lex="HHV-6">HHV-6</term>) strains</frag> <frag id="F2"><term sem="Virus" id="A1">GS</term></frag> and <frag id="F3"><term sem="Virus" id="A2">Z-29</term></frag></cons> in <term sem="Cell_natural" id="T6" lex="primary_human_T_lymphocyte">primary human T <term sem="Cell_natural" id="T7" lex="lymphocyte">lymphocytes</term></term> and identification of <term sem="DNA_family_or_group" id="T8" lex="transactivating_HHV-6(GS)_gene_fragment"><term sem="Virus" id="T9" lex="transactivating_HHV-6">transactivating HHV-6</term>(GS) gene fragments</term>.</sentence>
<event id="E1">
<type class="Positive_regulation" />
<theme idref="T1" />
<cause idref="A1" />
<clue><clueType>Transactivation</clueType> <linkTheme>of</linkTheme> the human immunodeficiency virus promoter <linkCause>by</linkCause> human herpesvirus 6 (HHV-6) strains GS and Z-29 <clueLoc>in primary human T lymphocytes</clueLoc> and identification of transactivating HHV-6(GS) gene fragments.</clue>
</event>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="T1" />
<cause idref="A2" />
<clue><clueType>Transactivation</clueType> <linkTheme>of</linkTheme> the human immunodeficiency virus promoter <linkCause>by</linkCause> human herpesvirus 6 (HHV-6) strains GS and Z-29 <clueLoc>in primary human T lymphocytes</clueLoc> and identification of transactivating HHV-6(GS) gene fragments.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term sem="Virus" id="T10" lex="human_herpesvirus_6">Human herpesvirus 6</term> (<term sem="Virus" id="T11" lex="HHV-6">HHV-6</term>) can activate the <term sem="DNA_domain_or_region" id="T12" lex="human_immunodeficiency_virus_(HIV)_promoter"><term sem="Virus" id="T13" lex="human_immunodeficiency_virus">human immunodeficiency virus</term> (<term sem="Virus" id="A100">HIV</term>) <term sem="DNA_domain_or_region" id="A101">promoter</term></term> and accelerate <term sem="Other" id="A3">cytopathic effects</term> in <term sem="Cell_natural" id="T14" lex="HIV-infected_human_T_cell"><term sem="Virus" id="A61">HIV</term>-infected <term sem="Cell_natural" id="A60">human T cells</term></term>.</sentence>
<event id="E3">
<type class="Positive_regulation" />
<theme idref1="A101" idref="A100" />
<cause idref="T11" />
<clue>Human herpesvirus 6 (HHV-6) can <clueType>activate</clueType> the human immunodeficiency virus (HIV) promoter and accelerate cytopathic effects in HIV-infected human T cells.</clue>
</event>
<event id="E6">
<type class="Positive_regulation" />
<theme idref="A3" />
<cause idref="T11" />
<clue>Human herpesvirus 6 (HHV-6) can activate the human immunodeficiency virus (HIV) promoter and <clueType>accelerate</clueType> cytopathic effects <clueLoc>in HIV-infected human T cells</clueLoc>.</clue>
</event>
<event id="E106">
<type class="Initiation_of_viral_infection" />
<theme idref="A60" />
<theme idref="A61" />
<clue>Human herpesvirus 6 (HHV-6) can activate the human immunodeficiency virus (HIV) promoter and accelerate cytopathic effects in HIV-<clueType>infected</clueType> human T cells.</clue>
</event>
<sentence id="S3">This study examines the regions of the <term sem="DNA_domain_or_region" id="T15" lex="HIV_promoter">HIV promoter</term> required for <term sem="Other" id="T16" lex="HHV-6_transactivation"><term sem="Virus" id="T17" lex="HHV-6">HHV-6</term> transactivation</term> in a heterogeneous population of <term sem="Cell_natural" id="T18" lex="primary_human_T_lymphocyte">primary human T lymphocytes</term> with or without <term sem="Other" id="T19" lex="antigenic_stimulation">antigenic stimulation</term>.</sentence>
<event id="E7">
<type class="Positive_regulation" />
<theme idref="T17" />
<clue>This study examines the regions of the HIV promoter required for HHV-6 <clueType>transactivation</clueType> in a heterogeneous population of primary human T lymphocytes with or without antigenic stimulation.</clue>
</event>
<event uncertainty="doubtful" id="E8">
<type class="Regulation" />
<theme idref="E7" />
<cause idref="T15" />
<cause idref="T19" />
<clue>This study examines the regions of the HIV promoter <clueType>required</clueType> <linkTheme>for</linkTheme> HHV-6 transactivation <clueLoc>in a heterogeneous population of primary human T lymphocytes</clueLoc> <corefCause>with</corefCause> or without antigenic stimulation.</clue>
</event>
<event uncertainty="doubtful" id="E9">
<type class="Regulation" />
<theme idref="E7" />
<cause idref="T15" />
<clue>This study examines the regions of the HIV promoter <clueType>required</clueType> <linkTheme>for</linkTheme> HHV-6 transactivation <clueLoc>in a heterogeneous population of primary human T lymphocytes</clueLoc> with or without antigenic stimulation.</clue>
</event>
<sentence id="S4">Two different strains of <term sem="Virus" id="T20" lex="HHV-6">HHV-6</term>, <term sem="Virus" id="T21" lex="GS">GS</term> and <term sem="Virus" id="T22" lex="Z29">Z29</term>, transactivated the <term sem="DNA_domain_or_region" id="T23" lex="HIV_promoter">HIV promoter</term>.</sentence>
<event id="E10">
<type class="Positive_regulation" />
<theme idref="T23" />
<cause idref="T21" />
<clue>Two different strains of HHV-6, GS and Z29, <clueType>transactivated</clueType> the HIV promoter.</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="T23" />
<cause idref="T22" />
<clue>Two different strains of HHV-6, GS and Z29, <clueType>transactivated</clueType> the HIV promoter.</clue>
</event>
<sentence id="S5">The <term sem="Virus" id="T24" lex="GS_strain">GS strain</term> transactivated the <term sem="DNA_domain_or_region" id="T25" lex="promoter">promoter</term> in both stimulated and resting <term sem="Cell_natural" id="T26" lex="T_cell">T cells</term>, while the <term sem="Virus" id="T27" lex="Z29_strain">Z29 strain</term> increased <term sem="Other" id="T28" lex="HIV_promoter_activity"><term sem="DNA_domain_or_region" id="T29" lex="HIV_promoter">HIV promoter</term> activity</term> only in <term sem="Cell_natural" id="T30" lex="stimulated_T_cell">stimulated <term sem="Cell_natural" id="A62">T cells</term></term>.</sentence>
<event id="E12">
<type class="Positive_regulation" />
<theme idref="T25" />
<cause idref="T24" />
<clue>The GS strain <clueType>transactivated</clueType> the promoter <clueLoc>in</clueLoc> both <clueLoc>stimulated</clueLoc> and resting <clueLoc>T cells</clueLoc>, while the Z29 strain increased HIV promoter activity only in stimulated T cells.</clue>
</event>
<event id="E212">
<type class="Positive_regulation" />
<theme idref="T25" />
<cause idref="T24" />
<clue>The GS strain <clueType>transactivated</clueType> the promoter <clueLoc>in</clueLoc> both stimulated and <clueLoc>resting T cells</clueLoc>, while the Z29 strain increased HIV promoter activity only in stimulated T cells.</clue>
</event>
<event id="E112">
<type class="Physiological_process" />
<theme idref="T26" />
<clue>The GS strain transactivated the promoter in both <clueType>stimulated</clueType> and resting T cells, while the Z29 strain increased HIV promoter activity only in stimulated T cells.</clue>
</event>
<event id="E13">
<type class="Positive_regulation" />
<theme idref="T28" />
<cause idref="T27" />
<clue>The GS strain transactivated the promoter in both stimulated and resting T cells, while the Z29 strain <clueType>increased</clueType> HIV promoter activity only <clueLoc>in stimulated T cells</clueLoc>.</clue>
</event>
<event id="E113">
<type class="Positive_regulation" />
<theme idref="A62" />
<clue>The GS strain transactivated the promoter in both stimulated and resting T cells, while the Z29 strain increased HIV promoter activity only in <clueType>stimulated</clueType> T cells.</clue>
</event>
<sentence id="S6"><term sem="DNA_molecule" id="A63">Three DNA clones containing <term sem="DNA_molecule" id="T31" lex="HHV-6(GS)_genomic_fragment">HHV-6(GS) genomic fragments</term></term> transactivated the <term sem="DNA_domain_or_region" id="T32" lex="HIV_promoter">HIV promoter</term> in <term sem="Cell_cultured" id="T33" lex="cotransfected_T_cell">cotransfected <term sem="Cell_natural" id="A64">T cells</term></term>.</sentence>
<event id="E14">
<type class="Positive_regulation" />
<theme idref="T32" />
<cause idref="T31" />
<clue>Three DNA clones containing HHV-6(GS) genomic fragments <clueType>transactivated</clueType> the HIV promoter <clueLoc>in cotransfected T cells</clueLoc>.</clue>
</event>
<event id="E114">
<type class="Artificial_process" />
<theme idref="A63" />
<theme idref="A64" />
<clue>Three DNA clones containing HHV-6(GS) genomic fragments transactivated the HIV promoter in <clueType>cotransfected</clueType> T cells.</clue>
</event>
<sentence id="S7">A <term sem="DNA_molecule" id="T34" lex="21.4-kb_DNA_clone">21.4-kb DNA clone</term>, <term sem="DNA_molecule" id="T35" lex="pZVB70">pZVB70</term>, showed the highest <term sem="Other" id="T36" lex="transactivating_ability">transactivating ability</term>, while two other <term sem="DNA_molecule" id="T37" lex="DNA_fragments">DNA fragments</term>, <term sem="DNA_molecule" id="T38" lex="pZVB10">pZVB10</term> (6.2 kb) and <term sem="DNA_molecule" id="T39" lex="pZVH14">pZVH14</term> (8.7 kb), showed lower activity.</sentence>
<event id="E15">
<type class="Positive_regulation" />
<theme idref="T32" />
<cause idref="T35" />
<clue>A 21.4-kb DNA clone, pZVB70, <clueType>showed</clueType> the highest <clueType>transactivating ability</clueType>, while two other DNA fragments, pZVB10 (6.2 kb) and pZVH14 (8.7 kb), showed lower activity.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E16">
<type class="Positive_regulation" />
<theme idref="T32" />
<cause idref="T38" />
<clue>A 21.4-kb DNA clone, pZVB70, showed the highest transactivating ability, while two other DNA fragments, pZVB10 (6.2 kb) and pZVH14 (8.7 kb), <clueType>showed</clueType> lower <clueType>activity</clueType>.</clue>
<comment>NO COREFETHEME</comment>
</event>
<event id="E17">
<type class="Positive_regulation" />
<theme idref="T32" />
<cause idref="T39" />
<clue>A 21.4-kb DNA clone, pZVB70, showed the highest transactivating ability, while two other DNA fragments, pZVB10 (6.2 kb) and pZVH14 (8.7 kb), <clueType>showed</clueType> lower <clueType>activity</clueType>.</clue>
<comment>NO COREFETHEME</comment>
</event>
<sentence id="S8">One of these clones, <term sem="DNA_molecule" id="T40" lex="pZVH14">pZVH14</term>, activated the <term sem="DNA_domain_or_region" id="A7"><term sem="DNA_molecule" id="T41" lex="HIV_promoter_construct"><term sem="DNA_domain_or_region" id="T42" lex="HIV_promoter">HIV promoter</term> construct</term> containing a mutation in the <term sem="DNA_molecule" id="T43" lex="NF_kappa_B_site">NF kappa B site</term></term>.</sentence>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="A7" />
<cause idref="T40" />
<clue>One of these clones, pZVH14, <clueType>activated</clueType> the HIV promoter construct containing a mutation in the NF kappa B site.</clue>
<comment>TPS: A7</comment>
</event>
<event id="E119">
<type class="Mutagenesis" />
<theme idref="T43" />
<clue>One of these clones, pZVH14, activated the HIV promoter construct containing a <clueType>mutation</clueType> <linkTheme>in</linkTheme> the NF kappa B site.</clue>
<comment>ARTIFICIAL</comment>
</event>
<sentence id="S9">However, this <term sem="DNA_domain_or_region" id="T44" lex="mutated_NF_kappa_B_promoter">mutated <term sem="DNA_domain_or_region" id="A65">NF kappa B promoter</term></term> was not transactivated during <term sem="Other" id="T45" lex="HHV-6(GS)_infection"><term sem="Virus" id="T46" lex="HHV-6(GS)">HHV-6(GS)</term> infection</term> or after cotransfection with <term sem="DNA_molecule" id="T47" lex="pZVB70">pZVB70</term> or <term sem="DNA_molecule" id="T48" lex="pZVB10">pZVB10</term>.</sentence>
<event id="E20">
<type class="Initiation_of_viral_infection" />
<theme idref="T46" />
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) <clueType>infection</clueType> or after cotransfection with pZVB70 or pZVB10.</clue>
</event>
<event assertion="non-exist" id="E21">
<type class="Positive_regulation" />
<theme idref="T44" />
<cause idref="E20" />
<clue>However, this mutated NF kappa B promoter was not <clueType>transactivated</clueType> <linkCause>during</linkCause> HHV-6(GS) infection or after cotransfection with pZVB70 or pZVB10.</clue>
</event>
<event id="E200">
<type class="Gene_expression" />
<theme idref="T47" />
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) infection or after <clueType>cotransfection</clueType> <linkTheme>with</linkTheme> pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event id="E201">
<type class="Positive_regulation" />
<theme idref="E200" />
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) infection or after <clueType>cotransfection</clueType> with pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event id="E202">
<type class="Gene_expression" />
<theme idref="T48" />
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) infection or after <clueType>cotransfection</clueType> <linkTheme>with</linkTheme> pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event id="E203">
<type class="Positive_regulation" />
<theme idref="E202" />
<clue>However, this mutated NF kappa B promoter was not transactivated during HHV-6(GS) infection or after <clueType>cotransfection</clueType> with pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment>
</event>
<event assertion="non-exist" id="E22">
<type class="Positive_regulation" />
<theme idref="T44" />
<cause idref="E201" />
<clue>However, this mutated NF kappa B promoter was not <clueType>transactivated</clueType> during HHV-6(GS) infection or <linkCause>after</linkCause> cotransfection with pZVB70 or pZVB10.</clue>
</event>
<event assertion="non-exist" id="E23">
<type class="Positive_regulation" />
<theme idref="T44" />
<cause idref="E203" />
<clue>However, this mutated NF kappa B promoter was not <clueType>transactivated</clueType> during HHV-6(GS) infection or <linkCause>after</linkCause> cotransfection with pZVB70 or pZVB10.</clue>
</event>
<event id="E123">
<type class="Mutagenesis" />
<theme idref="A65" />
<clue>However, this <clueType>mutated</clueType> NF kappa B promoter was not transactivated during HHV-6(GS) infection or after cotransfection with pZVB70 or pZVB10.</clue>
<comment>ARTIFICIAL</comment>
</event>
<sentence id="S10">These data indicate that the <term sem="DNA_domain_or_region" id="A400"><term sem="DNA_domain_or_region" id="T49" lex="NF_kappa_B_sites">NF kappa B sites</term> of the <term sem="DNA_domain_or_region" id="T50" lex="HIV_promoter">HIV promoter</term></term> are essential for its <term sem="Other" id="T51" lex="transactivation">transactivation</term> during <term sem="Other" id="T52" lex="HHV-6(GS)_infection"><term sem="Virus" id="T53" lex="HHV-6(GS)">HHV-6(GS)</term> infection</term>.</sentence>
<event id="E29">
<type class="Initiation_of_viral_infection" />
<theme idref="T53" />
<clue>These data indicate that the NF kappa B sites of the HIV promoter are essential for its transactivation during HHV-6(GS) <clueType>infection</clueType>.</clue>
</event>
<event id="E30">
<type class="Positive_regulation" />
<theme idref="T50" />
<cause idref="E29" />
<clue>These data indicate that the NF kappa B sites of the HIV promoter are essential for <corefTheme>its</corefTheme> <clueType>transactivation</clueType> <linkCause>during</linkCause> HHV-6(GS) infection.</clue>
</event>
<event id="E31">
<type class="Positive_regulation" />
<theme idref="E30" />
<cause idref="A400" />
<clue>These data indicate that the NF kappa B sites of the HIV promoter are <clueType>essential</clueType> <linkTheme>for</linkTheme> its transactivation during HHV-6(GS) infection.</clue>
<comment>TPS: A400</comment>
</event>
<sentence id="S11">By increasing <term sem="Other" id="T54" lex="HIV_promoter_activity"><term sem="DNA_domain_or_region" id="T55" lex="HIV_promoter">HIV promoter</term> activity</term> in <term sem="Cell_natural" id="T56" lex="primary_T_lymphocyte">primary T lymphocytes</term>, <term sem="Virus" id="T57" lex="HHV-6">HHV-6</term> may consequently increase <term sem="Other" id="T58" lex="HIV_replication"><term sem="Virus" id="A5">HIV</term> replication</term>, leading to an increase in the <term sem="Other" id="A6">cytopathic effect</term> on <term sem="Cell_natural" id="T59" lex="coinfected_human_T_cell">coinfected human T cells</term>.</sentence>
<event id="E24">
<type class="Positive_regulation" />
<theme idref="T54" />
<cause idref="T57" />
<clue>By <clueType>increasing</clueType> HIV promoter activity <clueLoc>in primary T lymphocytes</clueLoc>, HHV-6 may consequently increase HIV replication, leading to an increase in the cytopathic effect on coinfected human T cells.</clue>
</event>
<event id="E25">
<type class="Viral_life_cycle" />
<theme idref="A5" />
<clue>By increasing HIV promoter activity in primary T lymphocytes, HHV-6 may consequently increase HIV <clueType>replication</clueType>, leading to an increase in the cytopathic effect on coinfected human T cells.</clue>
</event>
<event uncertainty="probable" id="E26">
<type class="Positive_regulation" />
<theme idref="E25" />
<cause idref="E24" />
<clue><linkCause>By</linkCause> increasing HIV promoter activity in primary T lymphocytes, HHV-6 may consequently <clueType>increase</clueType> HIV replication, leading to an increase in the cytopathic effect on coinfected human T cells.</clue>
</event>
<event id="E27">
<type class="Positive_regulation" />
<theme idref="A6" />
<clue>By increasing HIV promoter activity in primary T lymphocytes, HHV-6 may consequently increase HIV replication, leading to an <clueType>increase</clueType> <linkTheme>in</linkTheme> the cytopathic effect <clueLoc>on coinfected human T cells</clueLoc>.</clue>
</event>
<event uncertainty="probable" id="E28">
<type class="Positive_regulation" />
<theme idref="E27" />
<cause idref="E26" />
<clue>By increasing HIV promoter activity in primary T lymphocytes, HHV-6 may consequently increase HIV replication, <clueType>leading</clueType> <linkTheme>to</linkTheme> an increase in the cytopathic effect <clueLoc>on coinfected human T cells</clueLoc>.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
